PATTI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 28.298
AS - Asia 16.106
EU - Europa 13.361
SA - Sud America 2.915
AF - Africa 1.498
Continente sconosciuto - Info sul continente non disponibili 1.201
OC - Oceania 22
AN - Antartide 1
Totale 63.402
Nazione #
US - Stati Uniti d'America 27.093
SG - Singapore 8.285
CN - Cina 4.230
RU - Federazione Russa 4.053
IE - Irlanda 2.447
BR - Brasile 2.395
IT - Italia 2.116
UA - Ucraina 1.693
VN - Vietnam 1.215
CA - Canada 902
FR - Francia 871
KR - Corea 678
CI - Costa d'Avorio 540
DE - Germania 477
BD - Bangladesh 460
NG - Nigeria 424
SE - Svezia 378
IN - India 321
GB - Regno Unito 316
FI - Finlandia 242
NL - Olanda 176
AR - Argentina 157
SN - Senegal 152
ZA - Sudafrica 127
MX - Messico 122
HK - Hong Kong 115
PL - Polonia 115
IQ - Iraq 99
TR - Turchia 95
EC - Ecuador 89
CH - Svizzera 84
ES - Italia 82
AT - Austria 77
CO - Colombia 73
VE - Venezuela 67
UZ - Uzbekistan 64
JP - Giappone 63
PK - Pakistan 61
ID - Indonesia 57
BJ - Benin 54
CL - Cile 47
EG - Egitto 47
JM - Giamaica 44
GR - Grecia 39
MA - Marocco 39
LB - Libano 35
SA - Arabia Saudita 34
PY - Paraguay 31
TN - Tunisia 31
CZ - Repubblica Ceca 30
KE - Kenya 30
IR - Iran 27
PE - Perù 26
AE - Emirati Arabi Uniti 25
BG - Bulgaria 24
JO - Giordania 24
CR - Costa Rica 23
MY - Malesia 23
BE - Belgio 22
EU - Europa 21
IL - Israele 21
AZ - Azerbaigian 20
NP - Nepal 20
PH - Filippine 20
AU - Australia 18
DZ - Algeria 18
TH - Thailandia 17
LT - Lituania 16
HN - Honduras 15
HR - Croazia 15
TT - Trinidad e Tobago 15
DO - Repubblica Dominicana 14
OM - Oman 13
UY - Uruguay 13
AL - Albania 12
BO - Bolivia 12
ET - Etiopia 12
KZ - Kazakistan 12
PS - Palestinian Territory 12
BB - Barbados 11
GT - Guatemala 10
KG - Kirghizistan 10
PA - Panama 10
RO - Romania 10
SV - El Salvador 10
BH - Bahrain 9
HU - Ungheria 8
LV - Lettonia 8
RS - Serbia 7
BA - Bosnia-Erzegovina 6
CG - Congo 6
GE - Georgia 6
NI - Nicaragua 6
PT - Portogallo 6
AM - Armenia 5
MD - Moldavia 5
PR - Porto Rico 5
SY - Repubblica araba siriana 5
BS - Bahamas 4
KW - Kuwait 4
Totale 62.133
Città #
Dallas 5.212
Singapore 4.501
Santa Clara 2.618
Dublin 2.433
San Jose 2.050
Chandler 2.034
Jacksonville 1.823
Moscow 1.583
Ashburn 1.488
Boardman 1.036
Hefei 872
Council Bluffs 798
Nanjing 705
Lauterbourg 690
Seoul 675
Cambridge 657
Lawrence 656
Andover 644
Chicago 588
Toronto 581
Abidjan 540
Los Angeles 425
Catania 403
Ho Chi Minh City 402
Beijing 332
Des Moines 328
Houston 306
Hanoi 269
San Mateo 253
Wilmington 241
New York 224
Nanchang 219
Abuja 205
Civitanova Marche 196
Lagos 194
São Paulo 190
Munich 187
Shenyang 180
Buffalo 163
Hebei 160
Ottawa 153
Dakar 152
Saint Petersburg 147
Changsha 137
Jiaxing 135
Tianjin 131
Helsinki 125
Milan 103
Hong Kong 100
Lappeenranta 97
Rome 95
Orem 92
Amsterdam 87
Johannesburg 75
Pune 75
Rio de Janeiro 73
Warsaw 71
Dong Ket 69
Phoenix 68
Bremen 67
London 67
Seattle 67
Brooklyn 64
Grafing 63
San Francisco 59
Denver 57
Columbus 56
Washington 56
The Dalles 55
Cotonou 54
Palermo 54
Stockholm 54
Tokyo 54
Montreal 53
Norwalk 53
Chennai 50
Jinan 50
Naples 48
Redondo Beach 48
Belo Horizonte 47
Brasília 47
Da Nang 46
Haiphong 46
Atlanta 44
Bar Harbor 44
Poplar 42
Boston 41
Curitiba 40
Baghdad 39
Manchester 39
Zhengzhou 39
Dhaka 38
Porto Alegre 38
Frankfurt am Main 36
Mexico City 36
Charlotte 34
Hangzhou 34
Guangzhou 33
Ningbo 33
Den Haag 30
Totale 41.001
Nome #
6. Efficacy of a computer-assisted cognitive rehabilitation protocol on walking in Parkinson's disease patients with freezing of gait: a pilot study 301
A case of multiple autoimmunity complicated by SIADH 300
Magnetic fields exposure from high-voltage power lines and risk of amyotrophic lateral sclerosis in two Italian populations 222
Early Intensive Versus Escalation Approach: Ten‐Year Impact on Disability in Relapsing Multiple Sclerosis 186
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study 176
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort 175
Clinical and Lifestyle Factors and Risk of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study 170
Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: A randomized clinical trial 167
Incidence of multiple sclerosis in the province of Catania. A geo-epidemiological study 166
Management of dysphagia in multiple sclerosis: current best practice 162
An update on the safety of treating relapsing-remitting multiple sclerosis 156
Altered time course of changes in the hippocampal concentration of excitatory and inhibitory amino acids during kainate-induced epilepsy 154
Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience 154
The use of high-efficacy disease-modifying therapies in multiple sclerosis: recommendations from an expert Delphi consensus 151
"Valutazione della efficacia terapeutica di un derivato benzamidico (Tiapride) in alcune sindromi di interesse neurologico". 150
An update on the pharmacological management of pain in patients with multiple sclerosis 149
Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated 147
Computer-assisted cognitive rehabilitation on freezing of gait in Parkinson's disease: A pilot study 147
Cognitive impairment and "invisible symptoms" are not associated with CCSVI in MS 146
"BoNT/A treatment of Sialorrohea following neurological disorders 145
"Effetti della somministrazione cronica di Aloperidolo e Sulpiride sul contenuto di GABA nella Substantia Nigra del ratto". 145
A waves in electroneurography: differential diagnosis with other late responses 145
Neurophysiological tests in Multiple Sclerosis. A synthetic overview. 143
Cancer risk assessment in multiple sclerosis patients in the Eastern Sicily 143
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience 142
Amyotrophic lateral sclerosis spatial epidemiology in the Mount Etna region, Italy 142
Cognitive dysfunction in multiple sclerosis. A population based study in Catania, Sicily 138
CSF neurotoxic metals/metalloids levels in amyotrophic lateral sclerosis patients: comparison between bulbar and spinal onset 138
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 136
Are oligoclonal bands associated to lower retinal layer thickness at the time of relapsing remitting multiple sclerosis diagnosis? Evidence from an exploratory study 135
Lack of association between Toxocara canis and multiple sclerosis: A population-based case-control study 134
Can new chemical therapies improve the management of multiple sclerosis in children? 133
"Comparative effects of estrogens and Prolactin on nigro-striatal DAergic system: neurochemical and behavioral findings". 133
An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management 133
"Valutazione del behaviour motorio in condizioni di iperprolattinemia". 132
A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmartâ ¢â the FUTURE study 132
Analisi del cammino di bambini con paralisi cerebrale infantile: modificazioni della cinetica della caviglia dopo trattamento con tossina botulinica di tipo A 131
CCSVI and MS. A population-based case-control study in Catania, Sicily. 130
Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study) 129
A possible spatial and temporal cluster of multiple sclerosis in the town of Linguaglossa, Sicily: an update 129
"Influenza del sistema dopaminergico centrale sulla attivita' GABAergica del cervelletto". 129
A possible spatial and temporal cluster of multiple sclerosis in the town of Linguaglossa, Sicily 129
Early-Onset Alcohol Dependence and Multiple Sclerosis: Diagnostic Challenges 129
Can we define a rehabilitation strategy for cognitive impairment in progressive multiple sclerosis? A critical appraisal. 128
Personalized therapy in multiple sclerosis: an Italian Delphi consensus 127
Post-Cerebrovascular Stroke and Early Dysphagia Assessment: A Systematic Review 126
A dynamic interpretation of κFLC index for the diagnosis of multiple sclerosis: a change of perspective 126
"Convulsioni sperimentali indotte da iniezioni di acido Kainico nei nuclei cerebellari". 126
Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis: a real-world setting experience 126
Participant perspectives of a home-based palliative approach for people with severe multiple sclerosis: A qualitative study 126
"Comparative effect of chronic Haloperidol and Sulpiride treatment on nigral and striatal GABA content". 125
"Calcitonina and nigro-striatal system: neurochemical, behavioural and clinical data". 125
The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement 125
Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study 124
Environmental and occupational risk factors of amyotrophic lateral sclerosis: a population-based case control study 124
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience 124
Restless legs syndrome and multiple sclerosis: a population based case-control study in Catania, Sicily. 124
Relationship between brain atrophy and disability in a multi-site multiple sclerosis registry 123
Effects of Nintendo Wii Fit® balance exercise program on physical abilities and quality of life in Multiple Sclerosis patients 123
A case of Marburg variant multiple sclerosis: clinical impact after high dose cyclophosphamide treatment 123
Epilepsy and multiple sclerosis 122
Paediatric multiple sclerosis: A scoping review of patients’ and parents’ perspectives 122
"Effects of Hyper and Hypoprolactinemia on glutamate decarboxilase activity in medial basal Hypothalamus of male rat". 120
The Neutrophil-to-Lymphocyte Ratio is Related to Disease Activity in Relapsing Remitting Multiple Sclerosis 120
Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesis 119
"Modulazione del sistema dopaminergico nigro-striatale da parte di estrogeni e Prolattina: dati comportamentali e neurochimici". 119
Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany 119
Administration of subcutaneous interferon beta 1a in the evening: data from RELIEF study 119
Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA) 119
The Italian Multiple Sclerosis Register Experience With Cladribine 118
A real-world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described 'spasticity-plus syndrome' 118
Conformational Antibodies to Proteolipid Protein-1 and Its Peripheral Isoform DM20 in Patients With CNS Autoimmune Demyelinating Disorders 118
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 118
Changes in Anti-JCV Antibody Status in a Large Population of Multiple Sclerosis Patients Treated with Natalizumab 118
Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study 118
"Calcitonin effects on extrapyramidal system: clinical and experimenta data". 117
"La distonia: correlazione tra blink reflex e trattamento farmacologico con Reserpina". 117
The impact of outpatient rehabilitation on quality of life in multiple sclerosis 116
Inpatient versus outpatient rehabilitation for multiple sclerosis patients: effects on disability and quality of life 116
Frequency of celiac disease is not increased among multiple sclerosis patients 115
Clinical Evolution of Relapsing Remitting Late Onset Multiple Sclerosis: A Nine Year Follow-Up Study 115
Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study 115
Clinical, laboratory features, and prognostic factors in adult acute transverse myelitis: an Italian multicenter study 115
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 115
Migraine causes retinal and choroidal structural changes: evaluation with ocular coherence tomography 114
Placing CD20-targeted B cell depletion in multiple sclerosis therapeutic scenario: Present and future perspectives 114
Prevalence and Incidence of Multiple Sclerosis in the City of Biancavilla 114
Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy 114
Multicenter, prospective, observational study aimed at evaluating SAtivex efFEcts (effectiveness and tolerability) in a large population of Italian multiple sclerosis patients: SA. FE. study 113
Lack of evidence for Toxocara infection in Italian myelitis patients 113
Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis 113
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the Literature 112
Environmental and occupational exposure to heavy metals and metalloid and development of amyotrophic lateral sclerosis: a population-based case control study in Emilia-Romagna and Sicily. 112
Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS 112
Depressive symptoms correlate with disability and disease course in multiple sclerosis patients: An Italian multi-center study using the Beck Depression Inventory 112
Pharmacotherapeutic management of lower urinary tract symptoms in Multiple Sclerosis Patients 112
Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis 112
Palliative care in multiple sclerosis 111
Didattica delle encefalopatie spongiformi 111
A critical appraisal of daclizumab use as emerging therapy in multiple sclerosis. 111
Totale 13.387
Categoria #
all - tutte 234.767
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 234.767


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.936 0 693 30 87 703 17 683 142 360 12 153 1.056
2022/20236.985 698 208 103 493 711 1.247 34 1.237 1.833 61 262 98
2023/20242.825 178 419 152 162 115 459 80 166 33 94 622 345
2024/202511.637 99 1.576 818 382 2.348 1.066 341 519 1.094 1.524 788 1.082
2025/202627.986 1.528 2.237 4.889 1.898 4.340 4.357 3.612 778 1.336 1.380 901 730
2026/20271.675 645 1.030 0 0 0 0 0 0 0 0 0 0
Totale 63.402